Litigation Details for CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. (D.N.J. 2021)
✉ Email this page to a colleague
CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. (D.N.J. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-10-25 |
| Court | District Court, D. New Jersey | Date Terminated | 2024-02-14 |
| Cause | 28:1332 Diversity-Product Liability | Assigned To | Esther Salas |
| Jury Demand | Plaintiff | Referred To | Leda Dunn Wettre |
| Patents | 7,045,620; 7,612,199; 7,902,206; 8,158,644; 8,158,781; 8,193,196; 8,722,684 | ||
| Link to Docket | External link to docket | ||
Details for CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-01-26 | 210 | Opinion | number of prior art patents, including U.S. Patent Number 7,045,620 (“’620 Patent”), Number 7,612,199…following four patents: the ’355 Patent, the ’915 Patent, the ’415 Patent, and the ’257 Patent (together …absorption. (’355 Patent at 4:6–8; ’915 Patent at 1:24–31; ’415 Patent at 1:26–33; ’257 Patent at 1:26–33;… θ. (’355 Patent at 1:55–2:45; ’915 Patent at 1:58–67; ’415 Patent at 1:60–67; ’257 Patent at 1:60–67… The ’915 Patent, ’415 Patent, and ’257 Patent The remaining three patents in this case—the | External link to document |
| 2024-05-22 | 233 | Markman Opening Brief | includes patents that Defendants own. See Ex. L, U.S. Patent No. 7,612,199 (“the ’199 patent”) at claims…terms for U.S. Patent Nos. 9,186,355 (“the ’355 patent”), 10,556,915 (“the ’915 patent”), 10,745,415 …other patents. Therefore, the ’355 and ’099 patents are still at issue (collectively, the “Patents-in-…stated. 2 The Patents-in-Suit derive from two patent families. The ’355 patent is in one …represent patent family with its own specification. The ’099 patent belongs to a second patent family | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
